View in EDS PDF Full Text

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).

Saved in:
Bibliographic Details
Title: Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
Authors: De Grève J; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Van Meerbeeck J; Department of Thoracic Oncology, University Hospital, Gent, Belgium., Vansteenkiste JF; Department of Pneumology, University Hospital KU Leuven, Leuven, Belgium., Decoster L; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Meert AP; Department of Pneumology, Institut Jules Bordet, Brussels, Belgium., Vuylsteke P; Department of Medical Oncology, Clinique et Maternité Sainte-Elisabeth, Namur, Belgium., Focan C; Department of Medical Oncology, CHC Clinique Saint Joseph, Liège, Belgium., Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., Humblet Y; Department of Medical Oncology, Centre du Cancer de l'Université Catholique de Louvain, Brussels, Belgium., Berchem G; Department of Medical Oncology, Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg., Colinet B; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., Galdermans D; Department of Medical Oncology, ZNA Middelheim Hospital, Antwerp, Belgium., Bosquée L; Department of Respiratory Medicine, CHU Sart-Tilman, Liège, Belgium., Vermeij J; Department of Medical Oncology, ZNA Jan Palfijn, Merksem, Belgium., Dewaele A; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Geers C; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Schallier D; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Teugels E; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Source: PloS one [PLoS One] 2016 Mar 31; Vol. 11 (3), pp. e0147599. Date of Electronic Publication: 2016 Mar 31 (Print Publication: 2016).
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27032107
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22De+Grève+J%22">De Grève J</searchLink>; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Meerbeeck+J%22">Van Meerbeeck J</searchLink>; Department of Thoracic Oncology, University Hospital, Gent, Belgium.<br /><searchLink fieldCode="AU" term="%22Vansteenkiste+JF%22">Vansteenkiste JF</searchLink>; Department of Pneumology, University Hospital KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Decoster+L%22">Decoster L</searchLink>; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Meert+AP%22">Meert AP</searchLink>; Department of Pneumology, Institut Jules Bordet, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Vuylsteke+P%22">Vuylsteke P</searchLink>; Department of Medical Oncology, Clinique et Maternité Sainte-Elisabeth, Namur, Belgium.<br /><searchLink fieldCode="AU" term="%22Focan+C%22">Focan C</searchLink>; Department of Medical Oncology, CHC Clinique Saint Joseph, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Canon+JL%22">Canon JL</searchLink>; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium.<br /><searchLink fieldCode="AU" term="%22Humblet+Y%22">Humblet Y</searchLink>; Department of Medical Oncology, Centre du Cancer de l'Université Catholique de Louvain, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Berchem+G%22">Berchem G</searchLink>; Department of Medical Oncology, Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Colinet+B%22">Colinet B</searchLink>; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium.<br /><searchLink fieldCode="AU" term="%22Galdermans+D%22">Galdermans D</searchLink>; Department of Medical Oncology, ZNA Middelheim Hospital, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Bosquée+L%22">Bosquée L</searchLink>; Department of Respiratory Medicine, CHU Sart-Tilman, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Vermeij+J%22">Vermeij J</searchLink>; Department of Medical Oncology, ZNA Jan Palfijn, Merksem, Belgium.<br /><searchLink fieldCode="AU" term="%22Dewaele+A%22">Dewaele A</searchLink>; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Geers+C%22">Geers C</searchLink>; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Schallier+D%22">Schallier D</searchLink>; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Teugels+E%22">Teugels E</searchLink>; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2016 Mar 31; Vol. 11 (3), pp. e0147599. <i>Date of Electronic Publication: </i>2016 Mar 31 (<i>Print Publication: </i>2016).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27032107
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0147599
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0147599
    Titles:
      – TitleFull: Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: De Grève J
      – PersonEntity:
          Name:
            NameFull: Van Meerbeeck J
      – PersonEntity:
          Name:
            NameFull: Vansteenkiste JF
      – PersonEntity:
          Name:
            NameFull: Decoster L
      – PersonEntity:
          Name:
            NameFull: Meert AP
      – PersonEntity:
          Name:
            NameFull: Vuylsteke P
      – PersonEntity:
          Name:
            NameFull: Focan C
      – PersonEntity:
          Name:
            NameFull: Canon JL
      – PersonEntity:
          Name:
            NameFull: Humblet Y
      – PersonEntity:
          Name:
            NameFull: Berchem G
      – PersonEntity:
          Name:
            NameFull: Colinet B
      – PersonEntity:
          Name:
            NameFull: Galdermans D
      – PersonEntity:
          Name:
            NameFull: Bosquée L
      – PersonEntity:
          Name:
            NameFull: Vermeij J
      – PersonEntity:
          Name:
            NameFull: Dewaele A
      – PersonEntity:
          Name:
            NameFull: Geers C
      – PersonEntity:
          Name:
            NameFull: Schallier D
      – PersonEntity:
          Name:
            NameFull: Teugels E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2016 Mar 31
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1